Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Defining the gastrointestinal immune and microbiome response to shigella infection in children

Award Number: K01AI187720
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 06/01/2026
PERIOD OF PERFORMANCE END DATE: 05/31/2031

Group Awards By:

View Award Description

Defining the gastrointestinal immune and microbiome response to shigella infection in children - ABSTRACT Shigella causes severe diarrhea and dysentery in children under five years old living in low- and middle-income countries. Repeated bouts of this easily transmissible infection in children can lead to clinically severe malnutrition, impaired growth, lifelong morbidity, and death. The underlying mechanisms that are involved in the progression to severe disease in some children remain poorly understood. While host immunity can impact the course and severity of disease, most studies have focused on systemic immunity. However, mucosal immune markers—likely directly involved in pathogen clearance in the gut—are not well characterized. Additionally, the microbial communities in the infant gastrointestinal tract are crucial for the development and regulation of the mucosal immune system. The overall objective of this application is to identify mucosal immune and microbiome markers associated with susceptibility to Shigella infection in children. Our preliminary data indicate that Shigella infection and its abundance influence both microbiome and immune components in children. We will investigate the relationship between Shigella burden, microbiome composition, stool immune markers, and severity of diarrheal disease in a well-characterized cohorts of children less than 5 years of age who participated in the Vaccine Impact on Diarrhea in Africa (VIDA) study, a multi-site study designed to investigate the etiology of diarrheal diseases in three African countries. We will test samples from children stratified in four groups: those with Shigella infection (confirmed by qPCR) with or without diarrhea, and controls with or without diarrhea (caused by pathogens other than Shigella). We will examine age-related differences in mucosal immune and microbiome profiles across three age groups (0-11, 12-23, and 24-59 months) to assess age-associated features. Aim 1 will characterize the gastrointestinal microbiome profile associated with Shigella infection using metagenomic sequencing. Aim 2 will use proteomics to identify known and novel mucosal immune components elicited during Shigella infection. Aim 3 will apply statistical and machine learning tools to identify interaction patterns between microbiome and immune features that are associated with Shigella infection. This five-year career development program will expand my expertise in microbiome sequencing, mucosal immunology, and computational biology. The findings will add to our understanding of the gut immune-microbial interactions, shedding light on their mechanisms of action and informing the development of effective prevention and therapeutic tools for children in vulnerable populations.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $159,764 )
2026	2026	UNIVERSITY OF MARYLAND, BALTIMORE	220 ARCH ST OFC LEVEL2	BALTIMORE	MD	21201	BALTIMORE CITY	USA	Allergy and Infectious Diseases Research	000	1	5/28/2026	NEW	$159,764
														Subtotal = $159,764

Grand Total All Awards = $159,764

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Defining the gastrointestinal immune and microbiome response to shigella infection in children

Award Number: K01AI187720

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 06/01/2026

PERIOD OF PERFORMANCE END DATE: 05/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer